Sort by
Refine Your Search
-
Post Summary To undertake a structured PhD in pharmaceutical innovation under the principal supervision of Professor John Gilmer with co-supervision from Professors Mantalaris and Long (Medicine
-
Post Summary The School of Pharmacy and Pharmaceutical Sciences at Trinity College, the University of Dublin, is seeking a candidate for a ‘PhD Studentship - Panoz Pharmaceutical Innovation in
-
genetic and immunophenotypic changes before they occur and can help drive the desired function. The aim of this PhD studentship is to characterize and direct cellular heterogeneity as a function of
-
Post Summary Background: Medicines optimisation improves medication appropriateness and reduces medication related adverse effects and harm. A medicines optimisation tool, OPTIMA-ID (Optimising Pharmaco-Therapy and Improving Medication for Ageing with Intellectual Disability) was recently...
-
Post Summary The Irish Longitudinal Study on Ageing (TILDA) at Trinity College Dublin, Ireland has an opportunity for a well-qualified applicant interested in PhD level research exploring the impact
-
to maximise the environmental benefits in the most cost-effective manner possible and will shape future policy in this area. An outstanding PhD student is sought for a 4-year fully funded project with
-
to maximise the environmental benefits in the most cost-effective manner possible and will shape future policy in this area. An outstanding PhD student is sought for a 4-year fully funded project with
-
Post Summary Applications are invited for a highly motivated PhD student to join an exciting new project that will use high density electromyography (EMG) and electroencephalography (EEG) to examine
-
to maximise the environmental benefits in the most cost-effective manner possible and will shape future policy in this area. An outstanding PhD student is sought for a 4-year fully funded project with
-
N=O CancerNet represents a collaborative six-countries network, encompassing leading universities and government organizations. In addition to our consortium beneficiaries, N=O CancerNet has gathered a diverse group of companies, hospitals, and internationally renowned cancer institutions. These...